{"altmetric_id":10017252,"selected_quotes":["Dr Lavasani discusses limiting the risk of nausea as a result of chemotherapy #ASCO2016"],"citation":{"altmetric_jid":"ecancerorg","first_seen_on":"2016-07-25T10:42:06+00:00","issns":[],"journal":"ecancer","last_mentioned_on":1469624401,"links":["http:\/\/ecancer.org\/video\/5042\/modern-antiematogenic-therapy-from-5-h3t-to-nk-1-antagonists.php"],"title":"Modern antiematogenic therapy from 5-H3T to NK-1 antagonists. Modern antiematogenic therapy from 5-H3T to NK-1 antagonists","type":"news","uri":"http:\/\/ecancer.org\/video\/5042\/modern-antiematogenic-therapy-from-5-h3t-to-nk-1-antagonists.php"},"altmetric_score":{"score":1.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.6},"context_for_score":{"all":{"total_number_of_other_articles":8137857,"mean":6.8794880300098,"rank":3807207,"this_scored_higher_than_pct":52,"this_scored_higher_than":4298330,"rank_type":"exact","sample_size":8137857,"percentile":52},"similar_age_3m":{"total_number_of_other_articles":257756,"mean":11.919962755329,"rank":117256,"this_scored_higher_than_pct":53,"this_scored_higher_than":138842,"rank_type":"exact","sample_size":257756,"percentile":53},"this_journal":{"total_number_of_other_articles":11791,"mean":2.8693384223919,"rank":4755,"this_scored_higher_than_pct":57,"this_scored_higher_than":6755,"rank_type":"exact","sample_size":11791,"percentile":57},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":1}}},"geo":{"twitter":{"GB":1,"US":1}}},"counts":{"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["ecancer","MCIStrong"],"posts_count":2},"facebook":{"unique_users_count":2,"unique_users":["486687201427642","180411582069499"],"posts_count":2}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ecancer\/statuses\/757525974401638400","license":"gnip","citation_ids":[10017252],"posted_on":"2016-07-25T10:40:41+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12889},"tweet_id":"757525974401638400"},{"url":"http:\/\/twitter.com\/MCIStrong\/statuses\/757586734532046848","license":"gnip","rt":["ecancer"],"citation_ids":[10017252],"posted_on":"2016-07-25T14:42:07+00:00","author":{"name":"Memorial Cancer Inst","url":"http:\/\/MemorialCancerInstitute.com","image":"https:\/\/pbs.twimg.com\/profile_images\/734784609355976704\/Ec0jN9ad_normal.jpg","description":"Care with a touch. At Memorial Cancer Institute, you are more than just a cancer patient.","id_on_source":"MCIStrong","tweeter_id":"2842458176","geo":{"lt":26.66396,"ln":-80.71617,"country":"US"},"followers":593},"tweet_id":"757586734532046848"}],"facebook":[{"title":"Modern antiematogenic therapy from 5-H3T to NK-1 antagonists. Modern antiematogenic therapy from 5-H3T to NK-1 antagonists. ecancer.tv - Essential viewing for oncologists","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1033014793461544&id=486687201427642","license":"public","citation_ids":[10017252],"posted_on":"2016-07-26T18:21:58+00:00","summary":"Dr. Lavasani speaks with ecancertv at the Best of ASCO 2016 about limiting the risk of nausea as a result of chemotherapy. She describes results from international teams, including adjuvant rolapitant and the impact of reduced dexamethasone exposure. WATCH","author":{"name":"Memorial Breast Cancer Services","url":"https:\/\/www.facebook.com\/486687201427642","facebook_wall_name":"Memorial Breast Cancer Services","image":"https:\/\/graph.facebook.com\/486687201427642\/picture","id_on_source":"486687201427642"}},{"title":"Modern antiematogenic therapy from 5-H3T to NK-1 antagonists. Modern antiematogenic therapy from 5-H3T to NK-1 antagonists. ecancer.tv - Essential viewing for oncologists","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=928499843927332&id=180411582069499","license":"public","citation_ids":[10017252],"posted_on":"2016-07-27T13:00:01+00:00","summary":"Dr Sayeh Lavasani of  Memorial Cancer Institute, Hollywood, Florida, USA speaks with ecancertv at the Best of ASCO 2016 about limiting the risk of nausea as a result of chemotherapy.\n\nShe describes results from international teams, including adjuvant rolap","author":{"name":"March For Cancer- 5k Run","url":"https:\/\/www.facebook.com\/180411582069499","facebook_wall_name":"March For Cancer- 5k Run","image":"https:\/\/graph.facebook.com\/180411582069499\/picture","id_on_source":"180411582069499"}}]}}